Coming Jan. 1: Legal Marijuana's Biggest Trigger Yet

Even after stacking up a bunch of double-, triple-, and even quadruple-digit gains over the last year and a quarter, many of my Roadmap to Marijuana Millions pot stocks still have plenty of gas left.

In fact, a few of my Canadian legal marijuana plays in particular have been on fire for months now - and especially since Nov. 10.

That's the day Canada's Department of Finance presented its cannabis tax plan. The Canadian government plans to add a $1-per-gram excise tax on cannabis products, or 10% of the sale price, whichever is higher. Plus, the tax plan reiterated Canada's commitment to legalize marijuana by July 2018.

No wonder my readers' "fast fortune" Canadian pot stocks jumped higher.

One of those stocks rose 15% the day that news broke... another soared 10% that day... another jumped 6.8%... and another picked up 13%.

But today we're talking about the one that gained 15% on Nov. 10. We're focusing on that one because it's gone on to soar 76% since then thanks to another catalyst entirely. And it's gained an amazing 766% since I first alerted my readers to it back in September 2016.

Today, I'll tell you about that stock - and the "second" catalyst that boosted its gains.

Plus, I've identified another "trigger" that's going to boost pot stocks on Jan. 1.

I want you to get in on these stocks before that catalyst hits.

And before mainstream investors catch on...

Legal Cannabis Will Grow 407.3%

Before we get to this Canadian company's huge surge, let's take a minute to remember why we're all here - why we've been jumping all over the legal cannabis market for more than a year now.

Legal marijuana sales in North America in 2016 totaled $6.7 billion. By 2025, legal sales in North America are projected to reach $24.5 billion.

That would be a 265.7% sales increase in just nine years.

Recreational and/or medical marijuana has been approved in 29 states (and Washington, D.C.) and in many countries around the world. And it's the reason why the global marijuana market topped $11 billion in 2016 - and could reach $55.8 billion by 2025.

That would be 407.3% growth.

And the top-tier cannabis companies - the ones I tell my members about - will watch their sales skyrocket. More sales will create more demand for pot stocks. And that demand will help send pot stock prices higher.

In other words, the legal cannabis sector is no longer the "Wild West"-style marketplace it was back in, say, 2013, even if there is still plenty of volatility compared with the placid broader markets.

That's why the right pot stocks reward forward-thinking investors with triple- and quadruple-digit gains. My Roadmap to Marijuana Millions model portfolio is chock-full of those kinds of stocks. Right now my paid-up members are sitting on gains of 816.7%... 766%... 417.6%... 214%... and five more triple-digit winners.

If you'd like to find out how to take advantage of this green revolution and get in on gains like those, click here.

Now let's talk about that 766% gainer...

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Why Aurora Has Soared 103% Since Nov. 10

Like I said, over-the-counter shares of Aurora Cannabis Inc. (OTCMKTS: ACBFF) bounced 15% right after the tax news broke last Friday.

But they were just getting started.

On Tuesday, Nov. 14, Aurora announced that it had plans to acquire CanniMed Therapeutics Inc. (OTCMKTS: CMMDF) for $3 billion. That represents a very nice premium of 56.9% over CanniMed's share price at the time.

So it's no surprise that it was off to the races for CanniMed - its shares are up 33.1% since the announcement.

While Aurora's shares took an immediate small hit as investors digested the news, they quickly recovered - and they're up 103% just since Nov. 10.

Investors - many of my readers among them - celebrated the deal because the combined companies, with a market cap of around $3 billion, would likely become the largest pure-play pot stock on the market.

Aurora, a Vancouver-based grower and dispenser, has been a pacesetter in forging partnerships in other provinces and countries. In its August quarterly report, Aurora announced record monthly revenue, shipments, and grams sold - and that it had surpassed 19,000 patients in the Aurora medical marijuana system.

That number of patients would pretty much double following an Aurora-CanniMed merger. Plus, all those CanniMed customers could start using Aurora's e-commerce platform.

The combined company would have five cultivation facilities, with more on the way. Altogether, Aurora-CanniMed could produce 130,000 kilograms of marijuana every year.

This would be a global concern. Aurora is making inroads in Germany and Australia. CanniMed is also in Australia. And both companies are looking to get into elsewhere in Europe... and even Africa.

That's all well and good - and it's been very nice for my paid-up Nova-X Report members who got in on Aurora early. Since Aurora first entered The Roadmap to Marijuana Millions' model portfolio on Sept. 2, 2016, its shares are up 766%.

I think Aurora's shares will keep rising as it acquires more small cannabis companies and becomes the No. 1 or No. 2 player in Canada.

But its extreme growth path may be over for now - especially as its executives keep diluting its shares.

That's not at all the case for the companies that will be affected by the next huge pot-stock "trigger" on the horizon.

I'm talking about full legalization in California.

Go West

Medical and adult recreational users alike will be able to use cannabis and buy from legitimate, regulated businesses starting Jan. 1 in California.

That will create an immediate $7 billion annual windfall for the state's legal marijuana business.

In fact, on Nov. 17, the California Bureau of Cannabis Control released 276 pages of regulations that the state's marijuana businesses must abide by.

These new rules lay out how recreational marijuana business must operate - everything from licensing fees and managing the seed-to-sale process... to regulations on where (not near schools) and when (till 10 p.m.) weed can be sold... to security (24-hour video surveillance is required).

While the new regulations do place some limits on certain growers, beyond that "there is no limitation for the other categories of licenses." That will allow large businesses to obtain as many licenses as they can afford, which threatens the viability of small farmers.

But that's okay for the legal marijuana investors who follow our advice here.

You see, I've identified the California penny pot stocks that are going to gain big now that these regulations are in place. And I'll be discussing exactly how investors can stake their claim in California's future $7 billion cannabis market during an upcoming free event.

I've scheduled this California Pot Stock Explosion Summit for this Thursday, Nov. 30, at 8 p.m. Eastern. We'll be broadcasting it live from Money Morning headquarters.

Now, space is limited - and time is running out - so you'll want to reserve your space now.

To do so, just click here.

The road to wealth is paved by tech, and Michael's Strategic Tech Investor puts you on the fast track to investing success with analysis, stock picks, and strategies that can double, triple – even quadruple your money quicker than any other sector on earth. Just click here to get started – it's absolutely free.

The post Coming Jan. 1: Legal Marijuana's Biggest Trigger Yet appeared first on Strategic Tech Investor.

About the Author

Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...

  • He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
  • He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
  • As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael's insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.

Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

And even with decades of experience, Michael believes there has never been a moment in time quite like this.

Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.

To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.

His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.

Read full bio